Antioxidant enzymes as redox-based biomarkers: a brief review
5
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
The field of redox proteomics focuses to a large extent on analyzing cysteine oxidation in proteins under different experimental conditions and states of diseases. The identification and localization of oxidized cysteines within the cellular milieu is critical for understanding the redox regulation of proteins under physiological and pathophysiological conditions, and it will in turn provide important information that are potentially useful for the development of novel strategies in the treatment and prevention of diseases associated with oxidative stress. Antioxidant enzymes that catalyze oxidation/reduction processes are able to serve as redox biomarkers in various human diseases, and they are key regulators controlling the redox state of functional proteins. Redox regulators with antioxidant properties related to active mediators, cellular organelles, and the surrounding environments are all connected within a network and are involved in diseases related to redox imbalance including cancer, ischemia/reperfusion injury, neurodegenerative diseases, as well as normal aging. In this review, we will briefly look at the selected aspects of oxidative thiol modification in antioxidant enzymes and thiol oxidation in proteins affected by redox control of antioxidant enzymes and their relation to disease.
Abstract
The field of redox proteomics focuses to a large extent on analyzing cysteine oxidation in proteins under different experimental conditions and states of diseases. The identification and localization of oxidized cysteines within the cellular milieu is critical for understanding the redox regulation of proteins under physiological and pathophysiological conditions, and it will in turn provide important information that are potentially useful for the development of novel strategies in the treatment and prevention of diseases associated with oxidative stress. Antioxidant enzymes that catalyze oxidation/reduction processes are able to serve as redox biomarkers in various human diseases, and they are key regulators controlling the redox state of functional proteins. Redox regulators with antioxidant properties related to active mediators, cellular organelles, and the surrounding environments are all connected within a network and are involved in diseases related to redox imbalance including cancer, ischemia/reperfusion injury, neurodegenerative diseases, as well as normal aging. In this review, we will briefly look at the selected aspects of oxidative thiol modification in antioxidant enzymes and thiol oxidation in proteins affected by redox control of antioxidant enzymes and their relation to disease.
참고문헌 (68)
- Alfadda AA, "Reactive oxygen species in health and disease", J Biomed Biotechnol, 2012, pp.936486~ (2012)
- Droge W, "Free radicals in the physiological control of cell function", Physiol Rev, 82, pp.47~95 (2002)
- Tsantes AE, "Redox imbalance, macrocytosis, and RBC homeostasis", Antioxid Redox Signal, 8, pp.1205~1216 (2006)
- Nickel C, "Thioredoxin networks in the malarial parasite Plasmodium falciparum", Antioxid Redox Signal, 8, pp.1227~1239 (2006)
- Wolff SP, "Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications", Br Med Bull, 49, pp.642~652 (1993)
- Dopheide JF, "Critical limb ischaemia is characterised by an increased production of whole blood reactive oxygen species and expression of TREM-1 on neutrophils", Atherosclerosis, 229, pp.396~403 (2013)
- Leitemperguer MR, "Assessment of ischemia-modified albumin levels in patients with rheumatoid arthritis", Clin Lab, 60, pp.1065~1070 (2014)
- Pierola J, "NADPH oxidase p22phox polymorphisms and oxidative stress in patients with obstructive sleep apnoea", Respir Med, 105, pp.1748~1754 (2011)
- Hsieh HL, "Role of redox signaling in neuroinflammation and neurodegenerative diseases", Biomed Res Int, 2013, pp.484613~ (2013)
- 박종길, "The role of peroxidases in the pathogenesis of atherosclerosis", BMB Reports, 44(8), pp.497~505 (2011), 생화학분자생물학회
- Milani P, "SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration", Oxid Med Cell Longev, 2013, pp.836760~ (2013)
- Saeidnia S, "Toxicological and pharmacological concerns on oxidative stress and related diseases", Toxicol Appl Pharmacol, 273, pp.442~455 (2013)
- Rinalducci S, "Redox proteomics:basic principles and future perspectives for the detection of protein oxidation in plants", J Exp Bot, 59, pp.3781~3801 (2008)
- Marino SM, "Analysis and functional prediction of reactive cysteine residues", J Biol Chem, 287, pp.4419~4425 (2012)
- Giannoni E, "Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth", Mol Cell Biol, 25, pp.6391~6403 (2005)
- Kim YM, "Hydrogen peroxide produced by angiopoietin-1 mediates angiogenesis", Cancer Res, 66, pp.6167~6174 (2006)
- Rhee SG, "Cell signaling. H2O2, a necessary evil for cell signaling", Science, 312, pp.1882~1883 (2006)
- Butterfield DA, "Mass spectrometry and redox proteomics: applications in disease", Mass Spectrom Rev, 33, pp.277~301 (2014)
- Kim HJ, "ROSics: Chemistry and proteomics of cysteine modifications in redox biology", Mass Spectrom Rev (2014)
- Hansen RE, "An introduction to methods for analyzing thiols and disulfides: Reactions, reagents, and practical considerations", Anal Biochem, 394, pp.147~158 (2009)
- Kim JR, "Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH", Anal Biochem, 283, pp.214~221 (2000)
- Charles RL, "Protein sulfenation as a redox sensor: proteomics studies using a novel biotinylated dimedone analogue", Mol Cell Proteomics, 6, pp.1473~1484 (2007)
- Mates JM, "Antioxidant enzymes and human diseases", Clin Biochem, 32, pp.595~603 (1999)
- Kinnula VL, "Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung", FEBS Lett, 569, pp.1~6 (2004)
- Scibior-Bentkowska D, "Cancer cells and oxidative stress", Postepy Hig Med Dosw, 63, pp.58~72 (2009)
- Jeong J, "Comprehensive identification of novel post-translational modifications in cellular peroxiredoxin 6", Proteomics, 12, pp.1452~1462 (2012)
- Cesaratto L, "Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia", reperfusion in human liver, 2005, pp.39, 255~268
- Wu CL, "Proteomic analysis of UVB-induced protein expression-and redox-dependent changes in skin fibroblasts using lysine-and cysteinelabeling two-dimensional difference gel electrophoresis", J Proteomics, 75, pp.1991~2014 (2012)
- Tsaytler PA, "Immediate protein targets of photodynamic treatment in carcinoma cells", J Proteome Res, 7, pp.3868~3878 (2008)
- Thongboonkerd V, "Renal and urinary proteomics: current applications and challenges", Proteomics, 5, pp.1033~1042 (2005)
- Tyther R, "Proteomic profiling of perturbed protein sulfenation in renal medulla of the spontaneously hypertensive rat", J Proteome Res, 9, pp.2678~2687 (2010)
- Choi J, "Oxidative modifications and aggregation of Cu, Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases", J Biol Chem, 280, pp.11648~11655 (2005)
- Matsuyama Y, "Albumin thiol oxidation and serum protein carbonyl formation are progressively enhanced with advancing stages of chronic kidney disease", Clin Exp Nephrol, 13, pp.308~315 (2009)
- Elias-Miró M, "Current knowledge on oxidative stress in hepatic ischemia", reperfusion, 2013, pp.47, 555~568
- Wilson CH, "Increased expression of peroxiredoxin 1 and identification of a novel lipid-metabolizing enzyme in the early phase of liver ischemia reperfusion injury", Proteomics, 11, pp.4385~4396 (2011)
- Kohr MJ, "Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia", reperfusion injury with resin-assisted capture, 2011, pp.108, 418~426
- Sun J, "Protein S-nitrosylation and cardioprotection", Circ Res, 106, pp.285~296 (2010)
- Li T, "Polymerized placenta hemoglobin attenuates ischemia", reperfusion injury and restores the nitroso-redox balance in isolated rat heart, 2009, pp.46, 397~405
- Butterfield DA, "Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications", Antioxid Redox Signal, 17, pp.1610~1655 (2012)
- Perluigi M, "Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis", Proteomics Clin Appl, 3, pp.682~693 (2009)
- Sultana R, "Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study", J Cell Mol Med, 11, pp.839~851 (2007)
- Anantharaman M, "Betaamyloid mediated nitration of manganese superoxide dismutase:implication for oxidative stress in a APPNLH", NLH X PS-1P264L, Am J Pathol, pp.2006, 168[DOI]
- Reed TT, "Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD", Brain Res, 1274, pp.66~76 (2009)
- Perluigi M, "Redox proteomics in aging rat brain: involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process", J Neurosci Res, 88, pp.3498~3507 (2010)
- Go YM, "The redox proteome", J Biol Chem, 288, pp.26512~26520 (2013)
- Thom SR, "Thioredoxin reductase linked to cytoskeleton by focal adhesion kinase reverses actin S-nitrosylation and restores neutrophil beta(2)integrin function", J Biol Chem, 287, pp.30346~30357 (2012)
- Saitoh M, "Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase(ASK)1", EMBO J, 17, pp.2596~2606 (1998)
- Marchand C, "Comparative proteomic approaches for the isolation of proteins interacting with thioredoxin", Proteomics, 6, pp.6528~6537 (2006)
- Hägglund P, "Identification of thioredoxin disulfide targets using a quantitative proteomics approach based on isotope-coded affinity tags", J Proteome Res, 7, pp.5270~5276 (2008)
- Go YM, "Selective targeting of the cysteine proteome by thioredoxin and glutathione redox systems", Mol Cell Proteomics, 12, pp.3285~3296 (2013)
- Finkelstein AE, "Auranofin. New oral gold compound for treatment of rheumatoid arthritis", Ann Rheum Dis, 35, pp.251~257 (1976)
- Floen MJ, "Thioredoxin-1 redox signaling regulates cell survival in response to hyperoxia", Free Radic Biol Med, 75, pp.167~177 (2014)
- Isaacs JS, "Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway", J Biol Chem, 277, pp.29936~29944 (2002)
- Aschner JL, "Heat shock protein 90 modulates endothelial nitric oxide synthase activity and vascular reactivity in the newborn piglet pulmonary circulation", Am J Physiol Lung Cell Mol Physiol, 292, pp.1515~1525 (2007)
- Spector D, "A genetic investigation of the essential role of glutathione: mutations in the proline biosynthesis pathway are the only suppressors of glutathione auxotrophy in yeast", J Biol Chem, 276, pp.7011~7016 (2001)
- Fukunaga Y, "Defining the roles of beta-catenin and plakoglobin in cell-cell adhesion: isolation of beta-catenin", plakoglobin-deficient F9 cells, 2005, pp.30, 25~34
- Neumann CA, "Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression", Nature, 424, pp.561~565 (2003)
- Zhang B, "Peroxiredoxins, a novel target in cancer radiotherapy", Cancer Lett, 286, pp.154~160 (2009)
- Aguilar-Melero P, "Proteomics in HepG2 hepatocarcinoma cells with stably silenced expression of PRDX1", J Proteomics, 79, pp.161~171 (2013)
- Fuentes-Almagro CA, "Identification of proteins containing redox-sensitive thiols after PRDX1, PRDX3 and GCLC silencing and", or glucose oxidase treatment in Hepa 1-6cells, 2012, pp.77, 262~279
- DeBerardinis RJ, "Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer", Oncogene, 29, pp.313~324 (2010)
- Park SH, "Antisense of human peroxiredoxin II enhances radiation-induced cell death", Clin Cancer Res, 6, pp.4915~4920 (2000)
- Chung YM, "Increased expression of peroxiredoxin II confers resistance to cisplatin", Anticancer Res, 21, pp.1129~1133 (2001)
- Rocha S, "Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis", Blood Cells Mol Dis, 41, pp.5~9 (2008)
- Matte A, "Peroxiredoxin-2expression is increased in beta-thalassemic mouse red cells but is displaced from the membrane as a marker of oxidative stress", Free Radic Biol Med, 49, pp.457~466 (2010)
- Lee TH, "Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice", Blood, 101, pp.5033~5038 (2003)
- Yang HY, "In-depth analysis of cysteine oxidation by the RBC proteome: advantage of peroxiredoxin II knockout mice", Proteomics, 12, pp.101~112 (2012)
- Fu C, "Elucidation of thioredoxin target protein networks in mouse", Mol Cell Proteomics, 8, pp.1674~1687 (2009)
